Stockreport

Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call

Vivos Therapeutics, Inc.  (VVOS) 
PDF LITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare service [Read more]